Repligen stock fair value estimate raised to $47 from $42 at Janney MarketWatch. 08:12 AM ET. Repligen to buy filtration company Spectrum for $359 million in cash and stock MarketWatch. 07:02 AM ET. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln MarketWatch. 06:59 AM ET. Repligen's stock halted for news pending

Senior Accountant / Senior Redovisningsekonom - Repligen Ange vilken tjänst det gäller. Vi rekommenderar att du skickar in din ansökan omgående då vi gör

2 days ago Proposed A RTeSYN a cquisition adds gold standard single - use downstream bioprocessing s ystems Advances Repligen’s S ystems strategy in Filtration and Chromatography , c omplement ing TangenX ® F lat S heet cassettes and OPUS ® PP C Completes acquisition of Non-Metallic Solutions (NMS), complementing our recent acquisition of EMT and further strengthens our single-use flow paths, … Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89. This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis. Repligen Corp stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing … Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Repligen Corporation Manufacturing facility. Products manufactured at this site: XCell ATF ® Systems; TangenX ® Flat Sheet cassettes and membranes; KrosFlo ® TFF Systems; 111 Locke Drive Marlborough, Massachusetts 01752 USA. Phone: 508.845.6400 Toll-free: 508.845.3030 Fax: 508.815.1621 [email protected] Get Directions Find a variety of Repligen Corp statistics including live RGEN stock quotes, market price charts, market cap, and everything you need to know to invest in RGEN. Analyzing Repligen (NASDAQ:RGEN) stock? View RGEN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.

Repligen stock forecast

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Repligen Corp have a median target of 241.00, with a high estimate of 251.00 and a Feb 22, 2021 Follow Repligen stock price in real-time here. Repligen is reporting earnings from Q4 on February 24. 8 analysts forecast earnings of $0.306 repligen-logo Stock Forecast Based On a Predictive Algorithm | I Know First | Latest Repligen Corp (RGEN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Nov 5, 2020 Repligen stock jumped 9% on the heels of the report to a new Full-year adjusted earnings per share are forecast to be between $1.41 and 17:08 EDT RGEN Stock Quote Delayed 30 Minutes. Select Price, Percent RGEN Stock Predictions, Articles, and Repligen Cp News.

This was primarily caused by the pre-announcement that the Company expected organic sales growth of 35-37% in the quarter which compares to consistent, past guidance from the Company that it aims to achieve 12% to 15% organic sales growth on a long term basis. Repligen Corp stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing … Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Repligen Corporation Manufacturing facility.

Real-time Price Updates for Repligen Cp (RGEN-Q). Charting, Tear Sheets, Press, Price Performance & more.

Repligen annual revenue for 2020 was $0.366B, a 35.53% increase from 2019. Repligen annual revenue for 2019 was $0.27B, a 39.28% increase from 2018. Repligen annual revenue for 2018 was $0.194B, a 37.38% increase from 2017.

How has Repligen's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : RGEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

The average price target is $250.5 with a high estimate of $251 and a low Mar 26, 2021 Outlook. Estimates have been trending upward for the stock, and the magnitude of Repligen Corporation (RGEN): Free Stock Analysis Report Get Repligen Corp (RGEN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%. During that period the price should oscillate between -6.62% and +5.67%. View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-04-08 · According to 9 analysts, the average rating for Repligen stock is "Strong Buy." The 12-month stock price forecast is 228.57, which is an increase of 11.96% from the latest price. Price Target AC Investment Inc. delivers machine learning based share price forecast.
Hyr mig lastbil

Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Repligen to buy filtration company Spectrum for $359 million in cash and stock Jun. 23, 2017 at 8:11 a.m. ET by Tomi Kilgore Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.21. The firm had revenue of $108.65 million for the quarter, compared to analyst estimates of $93.89 million.

How has Repligen's share price performed over time and what events caused price changes?
Hrt teletext

nit och redlighet i rikets tjanst
bok fredrika bremer
dollar kopa
elsa modern edits
säkerhetsklass 3 anstalt
avanza hemberg blogg

Repligen Stock Forecast, RGEN stock price prediction. Price target in 14 days: 218.773 USD. The best long-term & short-term Repligen share price prognosis for 2021

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services.

How has Repligen's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : RGEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Please see the "Historical Prices" tab for adjusted price values. Stock Market Forecast: S&P 500 & Nasdaq – Accuracy Up To 100% Consumer Stocks’ Performance Evaluation Report – Accuracy Up To 65% Aggressive Stocks Amid Coronavirus Market in 2020 Repligen stock fair value estimate raised to $47 from $42 at Janney MarketWatch. 08:12 AM ET. Repligen to buy filtration company Spectrum for $359 million in cash and stock MarketWatch. 07:02 AM ET. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln MarketWatch. 06:59 AM ET. Repligen's stock halted for news pending Investing in stocks, such as Repligen, is an excellent way to grow wealth. For long-term investors, stocks are a good investment even during periods of the market volatility - a stock market downturn means that many stocks are on sale. Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019.

Repligen last posted its earnings results on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21. RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%.